Immune system’s fight against cancer

Rebecca Obeng, MD, PhD, MPH, of Case Western Reserve University, investigated a long-acting form of the immune-boosting protein IL-7, called NT-I7, in a lung cancer model. The findings indicate that combining NT-I7 with existing PD-1-targeted therapies could further enhance treatment outcomes for cancer patients.